Tạp chí Tim mạch học Việt Nam

Article detail

Article detail description

Home
NGHIÊN CỨU LÂM SÀNG Issue: Số 71 - 2015 BỆNH MẠCH VÀNH

The combination of hs-CRP measurement with GRACE score for risk stratification of patients with acute coronary syndromes

Published: October 18, 2015
Views: 77

Abstract

Aim of the study: To determine the correlation between plasma hs-CRP concentration with GRACE risk score and the benefit of combining these two values in predicting in-hospital mortality of patients with acute coronary syndromes. Patients and methods: We performed an observational case-series in patients admitted to the Kien Giang general hospital with a diagnosis of acute coronary syndrome from October 2014 to April 2015. Plasma hs-CRP concentration was measured in a blood sample collected on admission. All patients were evaluated with the GRACE risk score. Area under the ROC curve, sensitivity and specificity of plasma hs-CRP concentration in predicting mortality were defined. The coefficient of correlation between plasma hs-CRP concentration and the GRACE score was calculated. In high-risk patients (GRACE score > 140), mortality of the two subgroups with plasma hs-CRP concentration above and below the threshold was compared. Results: 153 patients were included (8% had unstable angina, 21% had NSTEMI and 71% had STEMI). Patients’ mean age was 67,8, and 54,1% were men. 15 patients died (mortality 9,8%). Plasma hs-CRP concentration of these 15 patients was significantly higher compared to patients who survived. Area under the ROC curve was 0,868 (0,790-0,960). Plasma hs-CRP concentration ≥ 11,5 mg/l had a sensitivity of 93% and a specificity of 62% in predicting mortality. The coefficient of correlation r was 0,46 (p < 0,001). In high-risk patients, in-hospital mortality of the subgroups with plasma hs-CRP concentration ≥ 11,5 mg/l and < 11,5 mg/l was 27,4% and 2,9% (OR 12,9; p < 0,0001). Conclusions: In patients with acute coronary syndromes, the measurement of plasma hs-CRP concentration on admission greatly contributed to the prediction of in-hospital mortality, especially in patients with a high risk according to the GRACE score.

Keywords
No translate

References

1.
Elbarouni B, Goodman SG, Yan RT, et al. Validation of the Global Registry of Acute Coronary Events (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in Canada. Am Heart J 2009;158:392-399.
2.
Pieper KS, Gore JM, Fitzgerald G, et al. Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary Events. Am Heart J 2009;157:1097-1105.
3.
Yusufali A, Zubaid M, Al-Zakwani I, et al. Validation of the GRACE risk score for hospital mortality in patients with acute coronary syndrome in the Arab Middle East. Angiology 2011;62:390-396.
4.
Raposeiras-Roubin S, Barreiro PC, Rodino JB, et al. High-sensitivity C-reactive protein is a predictor of in-hospital cardiac events in acute myocardial infarction independently of GRACE risk score. Angiology 2012;63:30-34.
5.
Ribeiro DR, Ramos A, Vieira PL, et al. High-sensitivity C-reactive protein as a predictor of cardiovascular events after ST-elevation myocardial infarction. Arquivos brasileiros de cardiologia 2014;103:69-75.
6.
Hamm CW, Bassand JP, Agewall S, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054.
7.
Nguyễn Minh Đức. Khảo sát mối tương quan giữa hs-CRP và tổn thương giải phẫu động mạch vành ở bệnh nhân hội chứng vành cấp. Luận văn tốt nghiệp bác sĩ nội trú Nội tổng quát 2009. Đại học Y Dược TP. Hồ Chí Minh.
8.
Trương Phi Hùng, Đặng Vạn Phước. Nghiên cứu nồng độ hs-CRP bệnh nhân hội chứng vành cấp. Tạp chí Y học TP. Hồ Chí Minh 2007;11:80-85.
9.
Correia LC, Vasconcelos I, Garcia G, et al. Does C-reactive protein add prognostic value to GRACE score in acute coronary syndromes?. Arquivos brasileiros de cardiologia 2014;102:449-455.
10.
Diercks DB, Kirk JD, Naser S, et al. Value of high-sensitivity C-reactive protein in low risk chest pain observation unit patients. International J Emerg Med 2011;4:37.
11.
Võ La Cường. Nghiên cứu giá trị tiên lượng ngắn hạn của nồng độ hs-CRP và sự thay đổi sau điều trị bằng atorvastatin ở bệnh nhân hội chứng vành cấp. Luận án chuyên khoa cấp II 2014. Đại học Y Dược Cần Thơ.
12.
Lương Kim Liên. Khảo sát nồng độ hs-CRP ở bệnh nhân hội chứng vành cấp. Luận văn thạc sĩ y học Nội tổng quát 2007. Đại học Y Dược TP. Hồ Chí Minh.
13.
Nguyễn Quyền My. Kết hợp nồng độ hs-CRP huyết tương và thang điểm TIMI trong tiên lượng ngắn hạn bệnh nhân nhồi máu cơ tim ST chênh lên. Luận văn tốt nghiệp bác sĩ nội trú Nội khoa 2012. Đại học Y Dược Cần Thơ.
14.
Correia LC, Esteves JP. C-reactive protein and outcomes in acute coronary syndromes: a systematic review and meta-analysis. Arquivos brasileiros de cardiologia 2011;97:76-85.
15.
Raposeiras-Roubin S, Barreiro PC, Roubin-Camina F, et al. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction. Revista Portuguesa de Cardiologia 2013;32:117-122.

Tác giả

Danh Phước Quý: Bệnh viện Đa khoa Kiên Giang; Hồ Huỳnh Quang Trí: Viện Tim TP. Hồ Chí Minh;
The combination of hs-CRP measurement with GRACE score for risk stratification of patients with acute coronary syndromes

Files

Article Views77
Document Views0
Downloads9
Section NGHIÊN CỨU LÂM SÀNG
Category BỆNH MẠCH VÀNH
Pages 51-57
Copyright Holder 2015 Tạp chí Tim mạch học Việt Nam